共 50 条
- [1] Chemoimmunotherapy for stage IV non-small-cell lung cancer Reply [J]. LANCET ONCOLOGY, 2019, 20 (09): : E467 - E467
- [3] Predictors of benefits from frontline chemoimmunotherapy in stage IV non-small-cell lung cancer: a meta-analysis [J]. ONCOIMMUNOLOGY, 2019, 8 (12):
- [10] Stage IV Non-Small-Cell Lung Cancer in Older Patients: Survival analysis [J]. PSYCHO-ONCOLOGY, 2018, 27 : 112 - 113